Differential Cytokine Response in Host Defence Mechanisms Triggered by Gram-negative and Gram-positive Bacteria, and the Roles of Gabexate Mesilate, a Synthetic Protease Inhibitor

By Iwadou H   Morimoto Y   Iwagaki H   Sinoura S   Chouda Y   Kodama M   Yoshioka T   Saito S   Yagi T   Tanaka N  

The Journal of International Medical Research, Vol. 30, Iss. 2, 2002-03 ,pp. : 99-108

Field House Publishing

Access to resources Recommend Favorite

Advances in Mechanisms and Treatment Options of MINOCA Caused by Vasospasm or Microcirculation Dysfunction

By  

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 517-531

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

By Cassier Philippe A   Dufresne Armelle   Arifi Samia   Sayadi Hiba El   Labidi Intidar   Ray-Coquard Isabelle   Tabone Séverine   Méeus Pierre   Ranchère Dominique   Sunyach Marie-Pierre   Decouvelaere Anne-Valérie   Alberti Laurent   Blay Jean-Yves  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1211-1222

Informa Healthcare

Access to resources Recommend Favorite

Future options for imatinib mesilate-resistant tumors

By Sankhala Kamalesh K   Papadopoulos Kyriakos P  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1549-1560

Informa Healthcare

Access to resources Recommend Favorite

Imatinib mesilate: new perspectives in the treatment of solid tumours

By Smirne Carlo   Carbone Anna   Pirisi Mario   Bellone Graziella  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite